Cormorant Asset Management, LP
Position in OLMA — Olema Pharmaceuticals, Inc.
CIK 1583977
BOSTON, MA
Position in OLMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,896,500
-$31,252,500 QoQ
Shares Held
2,150,000
-44.9% QoQ
Ownership
2.46%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#12
of 182 holders
Holding Since
Dec 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OLMA Over Time
Shares Held
Position Value (USD)
Derivatives in OLMA
reported options exposure · as of Mar 31, 2026CallValue
$7,455,000
CallShares
500,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cormorant Asset Management, LP holds $1,889,506,429 across 46 Biotechnology names. OLMA ranks #21 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
640,000 | $214,265,600 | |
| 2 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
17,878,594 | $136,234,886 | |
| 3 | PBLS |
Parabilis Medicines, Inc.
|
4,615,612 | $126,329,300 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
2,657,521 | $110,738,900 | |
| 5 | ERAS |
Erasca, Inc.
|
6,000,000 | $109,920,000 | |
| 6 | EWTX |
Edgewise Therapeutics, Inc.
|
2,510,000 | $101,981,300 | |
| 7 | EYPT |
EyePoint, Inc.
|
7,000,000 | $100,100,000 | |
| 8 | ALMS |
Alumis Inc.
|
3,285,596 | $92,456,671 |
All Filings in OLMA
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,896,500 | 2,150,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $58,149,000 | 3,900,000 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $7,455,000 | 500,000 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $68,750,000 | 2,750,000 | Shares | Defined | 2026-02-17 | |
| 2023-12-31 | $34,468,904 | 2,456,800 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $55,633,835 | 4,504,764 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $27,830,460 | 3,082,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $10,694,540 | 3,082,000 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,100,900 | 2,082,000 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,746,320 | 2,082,000 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,473,740 | 2,082,000 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $8,869,320 | 2,082,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $20,309,992 | 2,169,871 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $84,705,246 | 3,073,485 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $85,996,110 | 3,073,485 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $106,028,149 | 3,195,544 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $153,641,755 | 3,195,544 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||